vimarsana.com
Home
Live Updates
Sonnet BioTherapeutics Implements Reverse Stock Split : vimarsana.com
Sonnet BioTherapeutics Implements Reverse Stock Split
Sonnet BioTherapeutics Holdings Inc. (SONN) will implement a 1-for-22 reverse stock split of its outstanding common stock at the commencement of trading today. In premarket trading today, the stock is up over 2,300% at $4.
Related Keywords
,
Sonnet Biotherapeutics Holdings Inc
,
Nasdaq Capital
,
Safety Monitoring Board
,
Nasdaq
,
Reverse Stock Split
,
Neuropathy
,
Bonn
,
vimarsana.com © 2020. All Rights Reserved.